ATE320272T1 - Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung - Google Patents

Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung

Info

Publication number
ATE320272T1
ATE320272T1 AT00993689T AT00993689T ATE320272T1 AT E320272 T1 ATE320272 T1 AT E320272T1 AT 00993689 T AT00993689 T AT 00993689T AT 00993689 T AT00993689 T AT 00993689T AT E320272 T1 ATE320272 T1 AT E320272T1
Authority
AT
Austria
Prior art keywords
contrast agents
produce
diagnostic agent
intestinal luminal
imaging
Prior art date
Application number
AT00993689T
Other languages
English (en)
Inventor
Michael V Knopp
Frederik Giesel
Tengg-Kobligk Hendrik Von
Jannis Radeleff
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI002735 external-priority patent/IT1315273B1/it
Priority claimed from IT2000MI000193A external-priority patent/IT1317816B1/it
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of ATE320272T1 publication Critical patent/ATE320272T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT00993689T 1999-12-29 2000-12-21 Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung ATE320272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002735 IT1315273B1 (it) 1999-12-29 1999-12-29 Imaging del colon mediante contrastografia.
IT2000MI000193A IT1317816B1 (it) 2000-02-08 2000-02-08 Imaging del colon mediante contrastografia.

Publications (1)

Publication Number Publication Date
ATE320272T1 true ATE320272T1 (de) 2006-04-15

Family

ID=26331700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00993689T ATE320272T1 (de) 1999-12-29 2000-12-21 Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung

Country Status (12)

Country Link
US (1) US20030113267A1 (de)
EP (1) EP1251875B1 (de)
JP (1) JP4798919B2 (de)
CN (1) CN1302814C (de)
AT (1) ATE320272T1 (de)
AU (1) AU2842901A (de)
CY (1) CY1105456T1 (de)
DE (1) DE60026743T2 (de)
DK (1) DK1251875T3 (de)
ES (1) ES2259299T3 (de)
PT (1) PT1251875E (de)
WO (1) WO2001049326A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7260174B2 (en) 2004-09-13 2007-08-21 General Electric Company Direct conversion energy discriminating CT detector with over-ranging correction
US7606347B2 (en) * 2004-09-13 2009-10-20 General Electric Company Photon counting x-ray detector with overrange logic control
US7599465B2 (en) 2004-11-19 2009-10-06 General Electric Company Detection of thrombi in CT using energy discrimination
US7209536B2 (en) * 2004-11-19 2007-04-24 General Electric Company CT colonography system
US7382853B2 (en) * 2004-11-24 2008-06-03 General Electric Company Method and system of CT data correction
US7583779B2 (en) * 2004-11-24 2009-09-01 General Electric Company System and method for acquisition and reconstruction of contrast-enhanced, artifact-reduced CT images
US7613274B2 (en) * 2007-11-16 2009-11-03 General Electric Company Method and system of energy integrating and photon counting using layered photon counting detector
ES2955349T3 (es) 2019-09-18 2023-11-30 Bayer Ag Predicción de imágenes MRI mediante un modelo de predicción entrenado por aprendizaje supervisado

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999445A (en) * 1988-06-10 1991-03-12 The Regents Of The University Of California Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5245282A (en) * 1991-06-28 1993-09-14 University Of Virginia Alumni Patents Foundation Three-dimensional magnetic resonance imaging
CA2115275A1 (en) * 1991-08-09 1993-02-18 David L. White Amino acid, ester and/or catechol contrast agents for mri
IT1252145B (it) * 1991-11-29 1995-06-05 Bracco Ind Chimica Spa Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
WO1993015093A1 (en) * 1992-01-29 1993-08-05 The Regents Of The University Of California Specific contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
IT1269839B (it) * 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
WO1998028258A1 (en) * 1996-12-23 1998-07-02 Bracco Research S.A. Compositions for increasing the mri contrast in visualising the digestive tract of patients

Also Published As

Publication number Publication date
AU2842901A (en) 2001-07-16
PT1251875E (pt) 2006-07-31
CN1413119A (zh) 2003-04-23
CN1302814C (zh) 2007-03-07
WO2001049326A1 (en) 2001-07-12
EP1251875B1 (de) 2006-03-15
US20030113267A1 (en) 2003-06-19
DE60026743D1 (de) 2006-05-11
JP4798919B2 (ja) 2011-10-19
JP2003519200A (ja) 2003-06-17
CY1105456T1 (el) 2010-04-28
DK1251875T3 (da) 2006-07-24
DE60026743T2 (de) 2006-08-17
ES2259299T3 (es) 2006-10-01
EP1251875A1 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE602005016148D1 (de) Targetingmittel für molekulare bilderzeugung
FI20021145A0 (fi) Laitteisto elintoimintojen mittaamiseksi
HUP0100159A2 (hu) Az Alzheimer-kór életben történő diagnosztizálására és amiloidlerakódás in vivo kimutatására és megelőzésére alkalmas vegyületek
ATE231004T1 (de) Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
ATE554395T1 (de) Diagnose septischer komplikationen
IL180896A0 (en) Method of tumour imaging
IS2522B (is) Mótefni fyrir ED-B-hneppi fibrónektíns, samsetningar, sem innihalda þau, og notkun þeirra til þess að sjúkdómsgreina og til þess að meðhöndla æxli og sjúkdóma, sem tengjast æðanýmyndun
CL2004001126A1 (es) Complejos de polimeros en cascada y sus composiciones farmaceuticas, utiles para la preparacion de agentes de diagnostico por nmr.
DE59811904D1 (de) Diagnosegerät zur bestimmung der remineralisierbarkeit von hartgewebe
DE60017665D1 (de) Trennbares Messgerät für die Impedanz eines lebenden Körpers
ATE320272T1 (de) Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung
DE602005011316D1 (de) Verfahren zur diagnose und behandlung von morbus crohn
IL175004A0 (en) Quick test for the diagnosis of alzheimer's disease
DE60207612D1 (de) Verbindungen zur bilddarstellung der alzheimer-krankenheit
WO2004100998A3 (en) Compositions and methods for non-invasive imaging of soluble beta-amyloid
NO20076119L (no) Diagnostisk markor for diabetiske vaskulaere komplikasjoner
ATE368262T1 (de) Akquisitionssystem für endoskopische bilder
DE50104761D1 (de) Messanordnung zur untersuchung eines gewebeabschnitts eines patienten
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
WO2001092476A3 (de) In vitro-gewebetestsystem
ATE337020T1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
MX2010007501A (es) Conjugados de n-alcoxiamida como agentes formadores de imagen.
AR056831A1 (es) Metodo para el diagnostico y tratamiento de enfermedades cardiovasculares

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1251875

Country of ref document: EP